Focused on developing therapies related to corticosteroid biology, the company operates as a small biopharmaceutical developer targeting inflammatory and immune-related conditions. Its value is tied largely to drug development progress, clinical trial outcomes, and regulatory milestones. Investors t...
1 member of Congress has disclosed 1 trade in Cortlanso (OVG), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-11-21 | JAMES B. RENACCI | sell | $100K – $250K |